An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction
about
The alliance of mesenchymal stem cells, bone, and diabetesTreatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetesOsteoporosis, fractures, and diabetes.Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes.Effect of 635 nm irradiation on high glucose-boosted inflammatory responses in LPS-induced MC3T3-E1 cells.Long Term Effect of High Glucose and Phosphate Levels on the OPG/RANK/RANKL/TRAIL System in the Progression of Vascular Calcification in rat Aortic Smooth Muscle CellsOsteoprotegerin in Cardiometabolic Disorders.Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact.Osteoprotegerin, vascular calcification and atherosclerosis.Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes.The role of osteoprotegerin in cardiovascular disease.Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.The Effects of Initial Periodontal Therapy on the Serum Receptor Activator of Nuclear Factor-κβ Ligand/Osteoprotegerin System in Patients With Type 2 Diabetes Mellitus and Periodontitis.TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects.SNP rs2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes.Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C.Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells.Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL.Effect of topical application of melatonin to the gingiva on salivary osteoprotegerin, RANKL and melatonin levels in patients with diabetes and periodontal disease.Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients.Reduced attenuation of bone resorption after oral glucose in type 2 diabetes.Exercise-induced vasodilation in healthy males: A marker of reduced endothelial function.Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg ParadoxIntravascular haemolysis in severe Plasmodium knowlesi malaria: association with endothelial activation, microvascular dysfunction, and acute kidney injury.
P2860
Q27012497-DFD79EEB-03BB-4501-B504-FA7C2D6806E5Q33803504-DFB7BB5B-D078-4CA6-B224-1B67FE5D11ABQ33891378-2AB561A3-8FE0-4172-AA67-60B9FC9F2867Q34229800-D1A852DD-66FF-4893-B62B-40E8D08DACE1Q34304606-7EE07FE3-1969-46F2-970B-E2E48A0FBE0BQ35127451-A6D19764-CF6A-47DA-9AED-552C9AFFDA1DQ35640787-3DFB1D21-CE6A-4381-9CF5-C46A1C8DA681Q35926521-A45DE774-F7B3-4390-A47F-35DB838B5617Q37285702-F1F53CAB-C921-49A3-A4CE-7C4CE8124D34Q37310825-D9CD7115-D72F-45F7-8186-99147D59674FQ37641079-3022F7EA-CFB2-471A-A0C4-5366CBFBCEF8Q38056541-921BA8B8-11D5-4C01-BD9D-8EEAAA7324DBQ38889912-2483F4ED-9653-45D2-90E4-17ECADD61DC9Q39197051-9445BC2B-8495-4587-B3D5-FC786D8ADBA3Q40041063-51214DB9-8A1C-4CF2-B5CE-CB26A8DF0B80Q40912538-F0B706DD-8EEE-4A8F-BE23-33A6A44DB576Q41123139-D983CD5B-7EF2-4BAC-B886-A572D587437AQ41317574-E6D588F4-3CDE-480B-AF3D-192EBEF749B5Q42181735-5799BCB8-E022-4AAF-92A0-95598AD868B3Q42443622-BA26436E-F4F3-4668-9CA3-89CEA150A5FBQ42489788-1DC8561B-10E8-436E-9DB7-B664409CB2BBQ44230417-E7EA1FAF-B82B-45EC-8F68-DF1741E5D2D2Q44498958-3C6C0EAE-1527-4985-A5AC-39EFBBA7D88BQ45865145-70B68B84-1C62-497A-94F8-FB73E829B4F4Q45941637-2051B7E5-7B88-47EB-9A47-E5D93061F466Q46844245-C646EAB5-1782-4B08-AD0A-E232846C69BCQ50950745-FDEB8CDE-EEA4-4312-98DE-1AA2E0098803Q51277910-EF258B25-F053-4C2E-A94D-669115D45EFEQ55285084-AA5F1B10-7B7D-4C7F-A6EF-AA5E833DC590Q55381832-337B86BD-9A01-4F5A-9DDB-D621C163E2DC
P2860
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@ast
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@en
type
label
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@ast
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@en
prefLabel
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@ast
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@en
P2093
P2860
P50
P1476
An increased osteoprotegerin s ...... o endothelial cell dysfunction
@en
P2093
Agostino Consoli
Claudio Celeghini
Federica Corallini
Riccardo Candido
P2860
P304
P356
10.2353/AJPATH.2006.060398
P407
P577
2006-12-01T00:00:00Z